Bacterial community-acquired pneumonia in HIV-infected patients

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 3, 2010, Pages 201-207

  Madeddu, Giordano ^a   Laura Fiori, Maria ^a   Stella Mura, Maria ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Bacterial community acquired pneumonia; Diagnosis; HIV; Management; Prevention; Risk factors

Indexed keywords

ANTIRETROVIRUS AGENT; BETA LACTAM; CD4 ANTIGEN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

CD4 LYMPHOCYTE COUNT; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LIVER CIRRHOSIS; OUTCOME ASSESSMENT; PROPHYLAXIS; REVIEW; STREPTOCOCCUS PNEUMONIAE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; INFECTION CONTROL; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77951045838     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283375825     Document Type: Review

References (46)

1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced immunodeficiency virus infection: HIV outpatient study investigators. N Engl J Med 1998; 338:853-860.
2. Mocroft A, Ledergerber B, Katlama C, et al. EuroSIDA study group: decline in the AIDS and death rates in the EuroSIDA study - an observational study. Lancet 2003; 362:22-29.
3. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 46:87-95.
4. Søgaard OS, Lohse N, Gerstoft J, et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish populationbased, nationwide cohort study. Clin Infect Dis 2008; 47:1347-1353.
5. Søgaard OS, Lohse N, Gerstoft J, et al. Mortality after hospitalization for pneumonia among individuals with HIV, 1995-2008: a Danish cohort study. PLoS One 2009; 4:e7022.
6. -1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
7. Ancelle-Park R. Expanded European AIDS: case definition. Lancet 1993; 341:441.
8. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995; 333:845-851.
9. Madeddu G, Porqueddu EM, Cambosu F, et al. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection 2008; 36:231-236.
10. Feldman C, Glatthaar M, Morar R, et al. Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults. Chest 1999; 116:107-114.
11. Gill CJ, Mwanakasale V, Fox MP, et al. Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women. J Infect Dis 2008; 197:1000-1005.
12. Lo YC, Lauderdale TL, Chang SY, et al. Streptococcus pneumoniae colonization among patients with human immunodeficiency virus-1 who had received 23-valent polysaccharide pneumococcal vaccine. J Microbiol Immunol Infect 2009; 42:234-242.
13. Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005; 20:1142-1145.
14. Burns DN, Hillman D, Neaton JD, et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:374-383.
15. Nieman RB, Fleming J, Coker RJ, et al. The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS 1993; 7:705-710.
16. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD41 count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355:2283-2296.
17. Gordin FM, Roediger MP, Girard PM, et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 2008; 178:630-636.
18. Manno D, Puoti M, Signorini L, et al. Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. Infection 2009; 37:334-339.
19. Malinis M, Myers J, Bordon J, et al. Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Int J Infect Dis 2009 [Epub ahead of print].
20. Curran A, Falco' V, Crespo M, et al. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med 2008; 9:609-615.
21. Boulware DR, Daley CL, Merrifield C, et al. Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. J Infect 2007; 55:300-309.
22. Dom?́nguez J, Gally N, Blanco S, et al. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest 2001; 119:243-249.
23. Marcos MA, Jimenez de Anta MT, de la Bellacasa JP, et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J 2003; 21:209-214.
24. Feldman C, Klugman KP, Yu VL, et al., International Pneumococcal Study Group. Bacteraemic pneumococcal pneumonia: impact of HIV on clinical presentation and outcome. J Infect 2007; 55:125-135.
25. Grau I, Ardanuy C, Liñares J, et al. Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease. HIV Med 2009; 10:488-495.
26. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of American/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2):S27-S72.
27. Woodhead M, Blasi F, Ewig S, et al., European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26:1138-1180.
28. British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001; 56 (Suppl 4):IV1-64.
29. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250.
30. Buie KA, Klugman KP, von Gottberg A, et al. Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and -uninfected adults with pneumococcal bacteremia. J Infect Dis 2004; 189:1996-2020.
31. Pemba L, Charalambous S, von Gottberg A, et al. Impact of cotrimoxazole on nonsusceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa. J Infect 2008; 56:171-178.
32. Goss CH, Rubenfeld GD, Park DR, et al. Cost and incidence of social comorbidities in low-risk patients with community acquired pneumonia admitted to a public hospital. Chest 2003; 124:2148-2155.
33. Valle's X, Marcos A, Pinart M, et al. Hospitalized community acquired pneumonia due to Streptococcus pneumoniae: has resistance to antibiotics decreased? Chest 2006; 130:800-806.
34. Gazzard B, Clumeck N, d'Arminio Monforte A, Lundgren JD. Indicator disease- guided testing: the next step for Europe? HIV Med 2008; 9 (Suppl 2): 34-40.
35. Rodriguez-Barradas MC, Goulet J, Brown S, et al. Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis 2008; 46:1093-1100.
36. French N, Nakiyingi J, Carpenter LM, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomized and placebo controlled trial. Lancet 2000; 355:2016-2111.
37. Rodriguez-Barradas MC, Musher DM, Lahart C, et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis 1992; 165:553-556.
38. Loeliger AF, Rijkers GT, Aerts P, et al. Deficient antipneumococcal polysaccharide responses in HIV-seropositive patients. FEMS Immunol Med Microbiol 1995; 12:33-41.
39. Sybil AT, Wallace MR, Rubins JB, et al. Reimmunization with 23-valent pneumococcal vaccine for patients infected with human immunodeficiency virus type-1: clinical, immunologic, and virologic responses. Clin Infect Dis 2002; 34:813-821.
40. Falcò V, Jordano Q, Cruz MJ, et al. Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study. Vaccine 2006; 24:2567-2574.
41. Peñaranda M, Falco V, Payeras A, et al. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study. Clin Infect Dis 2007; 45:82-87.
42. Hung CC, Chang SY, Su CT, et al. A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy. HIV Med 2010; 11:54-63.
43. Imaz A, Falcó V, Peñaranda M, et al. Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease. HIV Med 2009; 10:356-363.
44. Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007; 195:1018-1028.
45. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-970.
46. Klein MB, Lu Y, DelBalso L, et al. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis 2007; 45:234-240.